Adiba Sultana
Overview
Explore the profile of Adiba Sultana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
85
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sultana A, Alam M, Khanam A, Liang H
Comput Biol Med
. 2025 Mar;
:109919.
PMID: 40032537
No abstract available.
2.
Sultana A, Alam M, Khanam A, Liang H
Comput Biol Med
. 2025 Feb;
187:109744.
PMID: 39914199
Non-small-cell lung cancer (NSCLC) is one of the most malignant tumors and the leading cause of death from cancer worldwide and is increasing at a massive rate every year. Most...
3.
Sultana A, Alam M, Khanam A, Lin Y, Ren S, Singla R, et al.
J Biomol Struct Dyn
. 2024 Nov;
:1-15.
PMID: 39535278
Non-small-cell lung cancer (NSCLC) is one of the most deadly tumors characterized by poor survival rates. Advances in therapeutics and precise identification of biomarkers can potentially reduce the mortality rate....
4.
Sultana A, Migliori G, DAmbrosio L, Garcia-Garcia J, Silva D, Rendon L, et al.
J Bras Pneumol
. 2024 Oct;
50(4):e20240082.
PMID: 39356910
Objective: Many biologic agents cause some degree of immunosuppression, which can increase the risk of reactivation of tuberculosis infection (TBI). This risk is variable between individual biologics. We aimed to...
5.
Khanam A, Hridoy H, Alam M, Sultana A, Hasan I
Heliyon
. 2024 Sep;
10(17):e36935.
PMID: 39286192
Breast cancer emerges as one of the most prevalent malignancies in women, its incidence showing a concerning upward trend. Among the diverse array of breast cancer subtypes, triple-negative breast cancer...
6.
Alam M, Sultana A, Kibria M, Khanam A, Wang G, Haque Mollah M
Bioinform Biol Insights
. 2024 Sep;
18:11779322241272386.
PMID: 39239087
Breast cancer (BC) is a complex disease, which causes of high mortality rate in women. Early diagnosis and therapeutic improvements may reduce the mortality rate. There were more than 74...
7.
Alam M, Sultana A, Wang G, Haque Mollah M
Front Mol Biosci
. 2022 Dec;
9:1049741.
PMID: 36567949
Triple-negative breast cancer (TNBC) is one of the most lethal subtypes of breast cancer (BC), and it accounts for approximately 10%-20% of all invasive BCs diagnosed worldwide. The survival rate...
8.
Sultana A, Alam M, Liu X, Sharma R, Singla R, Gundamaraju R, et al.
Transl Oncol
. 2022 Nov;
27:101571.
PMID: 36401966
Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and the leading cause of cancer-related deaths worldwide. Identification of gene biomarkers and their regulatory factors and...
9.
Alam M, Sultana A, Sun H, Wu J, Guo F, Li Q, et al.
Front Pharmacol
. 2022 Oct;
13:942126.
PMID: 36204232
Accurate identification of molecular targets of disease plays an important role in diagnosis, prognosis, and therapies. Breast cancer (BC) is one of the most common malignant cancers in women worldwide....
10.
Alam M, Sultana A, Reza M, Amanullah M, Kabir S, Haque Mollah M
PLoS One
. 2022 May;
17(5):e0268967.
PMID: 35617355
Integrated bioinformatics and statistical approaches are now playing the vital role in identifying potential molecular biomarkers more accurately in presence of huge number of alternatives for disease diagnosis, prognosis and...